Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · IEX Real-Time Price · USD
14.01
-0.09 (-0.64%)
At close: Jul 2, 2024, 4:00 PM
14.03
+0.02 (0.14%)
After-hours: Jul 2, 2024, 7:07 PM EDT
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ELAN stock have an average target of 17.5, with a low estimate of 14 and a high estimate of 21. The average target predicts an increase of 24.91% from the current stock price of 14.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ELAN stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | +14.20% | Jul 1, 2024 |
| Barclays | Barclays | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +49.89% | Jun 28, 2024 |
| Piper Sandler | Piper Sandler | Hold Reiterates $18 → $19 | Hold | Reiterates | $18 → $19 | +35.62% | May 13, 2024 |
| Barclays | Barclays | Buy Maintains $19 → $23 | Buy | Maintains | $19 → $23 | +64.17% | May 9, 2024 |
| Piper Sandler | Piper Sandler | Hold Reiterates $12 → $18 | Hold | Reiterates | $12 → $18 | +28.48% | Mar 12, 2024 |
Financial Forecast
Revenue This Year
4.59B
from 4.42B
Increased by 3.80%
Revenue Next Year
4.80B
from 4.59B
Increased by 4.60%
EPS This Year
0.96
from -2.50
EPS Next Year
1.10
from 0.96
Increased by 14.48%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.7B | 5.1B | 5.4B | 5.6B | 6.0B |
| Avg | 4.6B | 4.8B | 5.0B | 5.2B | 5.5B |
| Low | 4.4B | 4.5B | 4.6B | 4.8B | 5.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.3% | 10.5% | 12.4% | 11.5% | 13.8% |
| Avg | 3.8% | 4.6% | 4.6% | 4.3% | 5.0% |
| Low | -1.0% | -1.2% | -3.9% | -3.6% | -4.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.02 | 1.21 | 1.34 | 1.45 | 1.76 |
| Avg | 0.96 | 1.10 | 1.20 | 1.34 | 1.57 |
| Low | 0.90 | 1.00 | 1.06 | 1.23 | 1.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 25.7% | 22.3% | 20.4% | 31.5% |
| Avg | - | 14.5% | 9.5% | 11.4% | 17.1% |
| Low | - | 4.1% | -3.7% | 1.8% | 2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.